GP Petroleums signed a share purchase agreement for a 22.45% stake in Incubit Pipavav Terminal, up to Rs.44.27 Crore. Payment is spread over one year in tranches.
GP Petroleums allotted 300 secured NCDs worth ₹30 Crore to RevX Special Credit Opportunities Fund II. The issue is within existing shareholder-approved borrowing limits.
GP Petroleums' postal ballot appointed two independent directors and approved up to Rs 100 Crore of preferential OCDs. The investor is RevX Special Credit Opportunities Fund II.
GP Petroleums filed its quarterly shareholding pattern for the period ended 30 September 2026. Promoter group holds 37.05% and public shareholders hold 62.95%.
GP Petroleums' postal ballot passed three resolutions, including two independent director appointments and an optionally convertible debenture preferential issue. All three were approved with the requisite majority.
H1 FY27 revenue ₹571.08 Cr (+84% YoY) and PAT ₹36.46 Cr (+206%). Q2 revenue hit a five-quarter high of ₹340.75 Cr (+124% YoY), but Q2 EBITDA margin fell to 6.2%.
GP Petroleums approved half-year results and leadership changes on 27 October 2026. Arjun Verma becomes Managing Director and Ayush Goel becomes Executive Chairman.
GP Petroleums reported Q2 FY27 revenue of ₹340.8 crore and PAT of ₹15.3 crore, up 179% YoY. The release also flags a board-approved plan to raise up to ₹130 crore via NCDs and OCDs.
GP Petroleums scheduled a board meeting for October 27, 2026, to consider and approve standalone and consolidated financial results for the quarter ended September 30, 2026.
GP Petroleums issued a corrigendum to its Postal Ballot notice regarding the proposed preferential issue of Optionally Convertible Debentures, updating conversion price and terms.
GP Petroleums Ltd has submitted its quarterly shareholding pattern for the period ending September 30, 2026, per Regulation 31(1)(b) compliance requirements.
GP Petroleums appointed Mr. Shirish Suvagia as Chief Financial Officer, succeeding Mr. Arjun Verma, who resigned from the role but remains a Whole-Time Director.
GP Petroleums approved acquiring a strategic stake in IPTPL for ₹44.27 Crore to strengthen Pipavav operations. CFO Arjun Verma resigns; Shirish Suvagia succeeds effective October 15.
GP Petroleums Limited has issued a Postal Ballot notice seeking shareholder approval for the appointment of two independent directors and a preferential issuance of convertible debentures.
GP Petroleums announced a Postal Ballot Notice seeking shareholder approval for appointing two Independent Directors and raising ₹100 Crore through Optionally Convertible Debentures (OCDs).
GP Petroleums Ltd approved issuing NCDs worth ₹30 Cr and Optionally Convertible Debentures (OCDs) worth ₹100 Cr to RevX Special Credit Opportunities Fund II via private placement.
GP Petroleums has intimated that its Board is scheduled for 30 Sep 2026 to consider a proposal to raise funds via debt securities. No decision or amount has been announced yet.
GP Petroleums announced resignation of Non-Executive Director Harshavardhan Sinha effective 19 Sept 2026. He is relocating to the UK and can no longer fulfil board duties.
GP Petroleums updated its exclusivity agreement with Incubit DMCC, clarifying the entity's name and reclassifying the USD 100,000 fee as a refundable deposit.
GP Petroleums has signed an Exclusivity Agreement with Incubit DMCC. This agreement allows the company to evaluate a potential strategic acquisition of assets in India and Africa.
GP Petroleums entered an Exclusivity Agreement with Incubit DMCC to evaluate a potential strategic acquisition of assets, paying a USD 100,000 (₹0.95 Crore) fee.
GP Petroleums Limited conducted its 43rd Annual General Meeting on August 26, 2026. Shareholders discussed and voted on financial statements, dividend, and director appointments.
GP Petroleums Ltd is entering an exclusivity agreement with Incubit DMCC for the potential acquisition of assets under "Project Petroleum" in India and Africa.
The Board approved an exclusivity agreement for 'Project Petroleum' with Incubit DMCC for a fee of USD 100,000. It deferred the proposal for NCD/OCD issuance.